Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Non-Current Deffered Revenue (2016 - 2019)

Forte Biosciences (FBRX) has disclosed Non-Current Deffered Revenue for 4 consecutive years, with $2.3 million as the latest value for Q1 2019.

  • Quarterly Non-Current Deffered Revenue rose 8414.81% to $2.3 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Mar 2019, up 8414.81% year-over-year, with the annual reading at $2.2 million for FY2018, 6013.89% up from the prior year.
  • Non-Current Deffered Revenue for Q1 2019 was $2.3 million at Forte Biosciences, up from $2.2 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $2.3 million in Q1 2019, with the low at $27000.0 in Q1 2018.
  • Average Non-Current Deffered Revenue over 4 years is $836100.0, with a median of $64500.0 recorded in 2016.
  • The sharpest move saw Non-Current Deffered Revenue crashed 55.74% in 2018, then soared 8414.81% in 2019.
  • Over 4 years, Non-Current Deffered Revenue stood at $68000.0 in 2016, then tumbled by 47.06% to $36000.0 in 2017, then skyrocketed by 6013.89% to $2.2 million in 2018, then rose by 4.45% to $2.3 million in 2019.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $2.3 million, $2.2 million, and $2.0 million for Q1 2019, Q4 2018, and Q3 2018 respectively.